Read + Share
Arriga R, Caratelli S, Lanzilli G, Ottaviani A, et al. CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated
colorectal carcinoma cells to cetuximab. Int J Cancer 2020;146:2531-2538.
PMID: 31396956
|
 |
|
Arriga R, Caratelli S, Lanzilli G, Ottaviani A, et al. CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated
colorectal carcinoma cells to cetuximab. Int J Cancer 2020;146:2531-2538.
PMID: 31396956
|
|
|
|